The Netherlands Cancer Institute
Clinical trials sponsored by The Netherlands Cancer Institute, explained in plain language.
-
New hope for High-Risk breast cancer: immunotherapy after standard care
Disease control Not yet recruitingThis phase 3 trial tests whether adding the immunotherapy drug pembrolizumab to standard post-surgery treatment can help prevent breast cancer from coming back in people with early-stage triple-negative breast cancer who still have cancer after initial chemo and immunotherapy. Ab…
Phase: PHASE3 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated May 26, 2026 05:13 UTC
-
New imaging study could reveal why some lung cancers respond better to targeted therapy
Knowledge-focused Not yet recruitingThis study will use a special PET scan to track a drug called trastuzumab in the bodies of 20 people with advanced lung cancer that has changes in the HER2 protein. The goal is to see if the drug builds up differently in tumors with a HER2 mutation compared to those with too much…
Phase: PHASE1 • Sponsor: The Netherlands Cancer Institute • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC